Intrinsic Value

Not Available for STEX

There is not enough data to reliably calculate the intrinsic value for Biosig Technologies Inc.

Do our valuations actually work? See backtest results .

Alternatives to STEX

Fundamental Analysis

What Biosig Technologies Does

Health Care

Biosig Technologies is a medical technology company that builds tools for cardiac electrophysiology, the specialty that studies and treats abnormal heart rhythms. Its main product is the PURE EP system, a recording and signal-processing platform used in hospital electrophysiology labs during procedures such as mapping and ablation. The company focuses on making the heart’s electrical signals clearer so doctors can work with more usable data.

Headquarters
United States of America US
Employees
50
IPO date
Sep 22, 2014
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q3 2026 · November 12, 2026

Streamex is positioning itself as a tokenized-commodities platform, extending GLDY through new distribution channels and Cask Foundation products while introducing a new brand.

Open the earnings call
EPS
−$0.09
Expected
−$0.03
Surprise
−200.0%
Stock, next trading day
+3.2%
View Earnings Call

Biosig Technologies insiders made their first purchases in five years

Insider trading · Last trade on Oct 1, 2026

Sold $390.6k 4 insiders
Bought $4.1m 4 insiders
Trades by date
Open insider trading

Past 12 months

Continue STEX Research

Decided on Biosig Technologies? Get an email when STEX reaches the price you’d buy at. Free with an account.

Back to Top